Standout Papers
- Hypervirulent (hypermucoviscous)Klebsiella pneumoniae (2013)
- Hypervirulent Klebsiella pneumoniae (2019)
- Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem (2003)
- Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance (2024)
Immediate Impact
40 from Science/Nature 62 standout
Citing Papers
A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome
2025 StandoutNature
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
Works of Thomas A. Russo being referenced
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
2017
An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas A. Russo | 5164 | 4581 | 2223 | 2322 | 121 | 8.9k | |
| Lenie Dijkshoorn | 7236 | 4420 | 1487 | 4276 | 129 | 10.5k | |
| Yoshichika Arakawa | 5151 | 2283 | 2653 | 2059 | 246 | 8.6k | |
| Edward Wai‐Chi Chan | 4635 | 1949 | 1247 | 1561 | 187 | 6.5k | |
| Richard Bonnet | 4346 | 2445 | 1377 | 4016 | 169 | 8.6k | |
| Andrea M. Hujer | 6260 | 2280 | 1662 | 2094 | 159 | 8.3k | |
| A. Philippon | 6157 | 2649 | 1467 | 1733 | 168 | 7.4k | |
| Xi Huang | 4255 | 1542 | 1059 | 2754 | 187 | 10.4k | |
| Joaquı́m Ruiz | 3606 | 2823 | 1176 | 1275 | 222 | 7.4k | |
| Michael R. Mulvey | 3571 | 1612 | 1789 | 2017 | 216 | 8.4k | |
| Tyrone L. Pitt | 3646 | 1857 | 1508 | 2968 | 145 | 7.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...